Chris Ehrlich
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Chris Ehrlich
Chris Ehrlich is recorded as Chairman, CEO and Board Member at Cero Therapeutics Holdings, Inc. (CERO). Cero Therapeutics Holdings, Inc. reported in an 8-K filed June 2, 2025 that Chris Ehrlich was appointed Chief Executive Officer, effective June 4, 2025. Cero Therapeutics Holdings, Inc. reported in an 8-K filed December 6, 2024 that Chris Ehrlich was appointed Chief Executive Officer, effective December 2, 2024. Cero Therapeutics Holdings, Inc. reported in an 8-K filed October 2, 2024 that Chris Ehrlich was appointed Interim Chairman and Chief Executive Officer, effective October 1, 2024. Equibles holds 6 filed executive changes naming Chris Ehrlich; each is listed under recent activity with its source filing. The proxy statement of Cero Therapeutics Holdings, Inc. reports total compensation of $998,748 for Chris Ehrlich in fiscal 2024, including a base salary of $90,000.
“under which the Company agreed to employ Mr. Ehrlich as the Company's Chief Executive Officer as of and from June 4, 2025.”
“On December 2, 2024, the Board approved the appointment of Mr. Ehrlich as Chief Executive Officer on a permanent, non-interim basis effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-06-04–present
-
Current
2024-02-14–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Cero Therapeutics Holdings, Inc.
Other people whose current roles at this company are on record from its filings.
- Brian G. Atwood CEO, Chairman
- Andrew Albert "Al" Kucharchuk CFO
- Andrew Albert Kucharchuk CFO
- Andrew Albert “Al” Kucharchuk CFO
- Charles Carter CFO
- Daniel Corey CTO, Board Member
- Eric Francois Board Member
- Lindsey Rolfe Board Member
- Lindsey Rolfe, M.D. Board Member
- Michael Byrnes Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Cero Therapeutics Holdings, Inc. (CERO) | Chief Executive Officer | $90,000 | $998,748 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.